# Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery

> **NCT03817359** · NA · COMPLETED · sponsor: **Tri-Service General Hospital** · enrollment: 84 (actual)

## Conditions studied

- Anesthetics
- Remifentanil
- Propofol

## Interventions

- **COMBINATION_PRODUCT:** Remifentanil-propofol mixture

## Key facts

- **NCT ID:** NCT03817359
- **Lead sponsor:** Tri-Service General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-03
- **Primary completion:** 2018-12-27
- **Final completion:** 2018-12-27
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03817359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03817359, "Use of a Remifentanil-propofol Mixture in Patients Undergoing Breast Cancer Surgery". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03817359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*